Antiphospholipid Syndrome in Pregnancy with a High-Risk Antibody Profile

This protocol covers the management of antiphospholipid syndrome (APS) in a pregnant woman who carries a high-risk antiphospholipid antibody (aPL) profile but has no prior history of thrombosis and no prior pregnancy complications.

Clinical Scenario

Female patient, currently pregnant, with a confirmed high-risk antiphospholipid antibody profile. No previous thrombotic events and no prior pregnancy complications. Despite the absence of a clinical history, the high-risk aPL profile identifies this pregnancy as requiring targeted prophylactic management.

Treatment Approach

For women in this specific situation, current guidance supports the use of low-dose aspirin during pregnancy. Full dosing, timing, and complete clinical decision criteria are available in the structured protocol →

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1136/annrheumdis-2019-215213

In women with a high-risk aPL profile but no history of thrombosis or pregnancy complications (with or without SLE), treatment with LDA (75–100 mg daily) during pregnancy should be considered.

View source ↗